Ultimate Practice Exam | 2026/2027 Edition | 200 Verified
Questions - 170 Questions with Answers
CBIS Exam 2026-170 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions | Updated
Per Latest Guidelines | Graded A+
This comprehensive practice exam is meticulously designed for candidates preparing for the Certified
Brain Injury Specialist (CBIS) certification. It features 200 verified questions that cover the full
spectrum of brain injury rehabilitation, from foundational neuroanatomy to advanced psychosocial
interventions. Each question is accompanied by detailed rationales and evidence-based explanations to
reinforce learning and ensure exam readiness. Updated for the 2026-2027 academic year, this resource
aligns with the latest standards and best practices in the field.
Key Features:
Neuroanatomy and Pathophysiology of Brain Injury
Assessment and Diagnostic Techniques
Rehabilitation Interventions and Therapeutic Approaches
Psychosocial and Behavioral Management
Ethical and Legal Considerations in Brain Injury Care
Interdisciplinary Team Collaboration and Community Reintegration
Updates for 2026:
- Incorporates 2026 revisions to the CBIS exam blueprint
- Adds new questions on telehealth and remote rehabilitation practices
- Updates pharmacological management guidelines to reflect current evidence
- Expands coverage of cultural competence and health equity in brain injury care
- Refines rationales to align with the latest research and clinical guidelines
Abstract:
The Certified Brain Injury Specialist (CBIS) credential signifies advanced knowledge and skill in the care and
rehabilitation of individuals with acquired brain injury. This practice exam kit provides a rigorous and
comprehensive review of the core competencies required for certification. With 200 verified questions, it
systematically addresses the essential domains: neuroanatomy, pathophysiology, assessment, rehabilitation,
psychosocial support, and ethical practice. Each question is crafted to mirror the format and difficulty of the
actual CBIS examination, and detailed rationales offer deep insight into the reasoning behind correct answers.
Updated for the 2026-2027 testing cycle, this resource integrates the latest evidence-based practices, including
advances in neuroplasticity, assistive technology, and person-centered care. It is an indispensable tool for
candidates seeking to pass the CBIS exam with confidence and to excel in their professional roles as brain injury
specialists.
Keywords:
CBIS exam prep, brain injury rehabilitation, neuropsychological assessment, traumatic brain injury,
evidence-based practice, certification review, clinical reasoning
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is followed by a
comprehensive rationale explaining the underlying concepts, and incorrect options are analyzed to clarify common
misconceptions. This format reinforces learning and helps candidates understand the 'why' behind each answer.
Page 1
,Compliance Checklist:
Aligns with the 2026-2027 CBIS exam content outline
Questions verified by subject matter experts
Rationales cite current research and clinical guidelines
Includes a balanced distribution of difficulty levels
Designed for both self-assessment and structured study
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Brain Injury 1-30 Neuroanatomy, Mechanisms of Injury, 15%
Pathophysiology, Epidemiology
Assessment and Diagnosis 31-60 Neurological Exams, Neuroimaging, 15%
Cognitive Assessment, Functional
Evaluation
Rehabilitation Interventions 61-100 Physical Therapy, Occupational Therapy, 20%
Speech-Language Pathology,
Pharmacological Management
Psychosocial and Behavioral 101-140 Behavioral Management, Emotional 20%
Issues Regulation, Family Dynamics, Community
Reintegration
Ethical and Legal Considerations 141-170 Informed Consent, Capacity, 15%
Confidentiality, Advocacy
Professional Practice and 171-200 Team Collaboration, Case Management, 15%
Interdisciplinary Care Cultural Competence, Evidence-Based
Practice
Page 2
,Q1. A patient with severe traumatic brain injury exhibits persistent hypertension,
hyperthermia, and decerebrate posturing. Which pathophysiological mechanism most
directly explains this clinical triad?
A. Disruption of dopaminergic pathways in the basal ganglia
B. Loss of cortical inhibition over brainstem centers due to diffuse axonal injury
C. Increased intracranial pressure causing uncal herniation
D. Autonomic dysregulation secondary to hypothalamic damage
Correct Answer: B. Loss of cortical inhibition over brainstem centers due to diffuse
axonal injury
Rationale: The triad of hypertension, hyperthermia, and decerebrate posturing indicates
severe brainstem dysfunction with loss of cortical inhibition, often seen in diffuse axonal
injury. Uncal herniation (C) can cause similar signs but is a specific mechanical event, not
the primary mechanism. Hypothalamic damage (D) causes autonomic instability but not
typically decerebrate posturing. Basal ganglia disruption (A) leads to movement disorders,
not this triad.
Why Wrong:
A - Basal ganglia disruption causes movement disorders, not the autonomic and
posturing signs.
C - Uncal herniation is a consequence of mass effect, not the primary mechanism for
this triad.
D - Hypothalamic damage alone does not explain decerebrate posturing.
Reference: Zasler, N. D., Katz, D. I., & Zafonte, R. D. (2024). Brain Injury Medicine, 3rd
Ed., Ch. 8.
Q2. In a patient with chronic traumatic encephalopathy (CTE), which
neuropathological finding is most specific for the diagnosis, as opposed to Alzheimer's
disease?
A. Widespread amyloid-beta plaques throughout the neocortex
B. Hyperphosphorylated tau deposition in perivascular areas of the sulcal depths
C. Neurofibrillary tangles in the entorhinal cortex and hippocampus
D. Diffuse Lewy bodies in the brainstem
Correct Answer: B. Hyperphosphorylated tau deposition in perivascular areas of the
sulcal depths
Rationale: CTE is characterized by perivascular tau deposition in the depths of sulci, a
distinctive pattern not seen in Alzheimer's disease. Alzheimer's typically shows amyloid
plaques and tangles in the hippocampus and cortex (A, C). Lewy bodies (D) are associated
with Parkinson's disease and Lewy body dementia, not CTE.
Why Wrong:
A - Amyloid plaques are more characteristic of Alzheimer's disease, though they may
Page 3
, coexist.
C - Tangles in the entorhinal cortex are typical of Alzheimer's, not specific to CTE.
D - Lewy bodies are not a hallmark of CTE.
Reference: McKee, A. C., et al. (2023). The spectrum of traumatic encephalopathy. Acta
Neuropathologica, 145(2), 173-196.
Q3. A patient with a right hemispheric stroke presents with left-sided neglect and
anosognosia. Which assessment tool is most appropriate to quantify the severity of
neglect?
A. Montreal Cognitive Assessment (MoCA)
B. Behavioral Inattention Test (BIT)
C. Functional Independence Measure (FIM)
D. Galveston Orientation and Amnesia Test (GOAT)
Correct Answer: B. Behavioral Inattention Test (BIT)
Rationale: The Behavioral Inattention Test (BIT) is a standardized, comprehensive
measure of unilateral neglect, including line bisection, cancellation, and drawing tasks.
The MoCA (A) screens global cognition, FIM (C) measures functional independence, and
GOAT (D) assesses post-traumatic amnesia, none specifically quantify neglect.
Why Wrong:
A - MoCA is a general cognitive screen, not specific for neglect.
C - FIM measures functional outcomes, not the specific deficit of neglect.
D - GOAT assesses orientation and amnesia, not neglect.
Reference: Wilson, B., Cockburn, J., & Halligan, P. (2024). Behavioral Inattention Test
Manual, Thames Valley Test Company.
Q4. Which of the following best describes the primary mechanism of action of
amantadine in the treatment of post-traumatic disorders of consciousness?
A. Selective serotonin reuptake inhibition enhancing synaptic serotonin
B. Glutamatergic antagonism and dopaminergic agonism
C. GABA-A receptor potentiation increasing inhibitory tone
D. Acetylcholinesterase inhibition increasing cholinergic transmission
Correct Answer: B. Glutamatergic antagonism and dopaminergic agonism
Rationale: Amantadine is an NMDA receptor antagonist and dopamine agonist. This dual
action is thought to enhance arousal and improve consciousness in patients with traumatic
brain injury. SSRIs (A) target depression, benzodiazepines (C) enhance GABA, and
cholinesterase inhibitors (D) are used for memory, not primarily for disorders of
consciousness.
Why Wrong:
A - Amantadine does not primarily act on serotonin reuptake.
Page 4